Ten (10) samples were acquired from organ donors and six from patients receiving liver transplantation for inborn errors of intermediary metabolism (1 Primary Hyperoxaluria, 2 Maple Syrup Urine Disease), including UCDs (1 OTC and 2 CPS-1 deficiencies). This evidence concerns the gene CPS1 and primary hyperoxaluria.